Clinical Trial Update: An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the safety of a brimonidine intravitreal implant in patients with Retinitis Pigmentosa. The study was a Phase 1/2 explorat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• Brimonidine intravitreal implant (brimonidine)

Snippet

Sponsor: Allergan | Conditions: Retinitis Pigmentosa | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-04-24